A/Prof Deme Karikios is a medical oncologist at Nepean Hospital in Sydney. He has a clinical and research interest in thoracic and gastrointestinal malignancies. Deme also has a research interest in costs and value of anticancer drugs, decisions about treatment with expensive unsubsidized anticancer drugs and financial toxicity. He was awarded his PhD in 2019, entitled “The consequences of rising anticancer drug costs in Australia” which he undertook at the NHMRC Clinical Trials Centre, University of Sydney.

Deme is an active member of the COSA Financial Toxicity Working Group.

Deme is a co-supervisor of several PhD students and a Clinical Associate Professor at the University of Sydney.

Deme has an interest in cancer care policy and is a past chair of the Medical Oncology Group of Australia (MOGA).